| Dr Hoang M Phan, MD | |
|
20110 Stoneview Dr, Richmond, TX 77407-4166 | |
| (832) 798-7326 | |
| Not Available |
| Full Name | Dr Hoang M Phan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 20110 Stoneview Dr, Richmond, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073717476 | NPI | - | NPPES |
| 8X6783 | Other | TX | BCBSTX |
| 189146701 | Medicaid | TX | |
| 1073717476 | Other | TX | TRICARE |
| 1073717476 | Other | TX | BCBS TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M6827 (Texas) | Primary |
| 208M00000X | Hospitalist | M6827 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Hospital | Houston, TX | Hospital |
| Houston Methodist The Woodlands Hospital | The woodlands, TX | Hospital |
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.
› Verified 2 days ago
| Entity Name | Hoang M. Phan Md,pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982138632 PECOS PAC ID: 6800163148 Enrollment ID: O20170517001138 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas-tcg Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902384464 PECOS PAC ID: 3678825312 Enrollment ID: O20181009000584 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hoang M Phan, MD 20110 Stoneview Dr, Richmond, TX 77407-4166 Ph: (832) 798-7326 | Dr Hoang M Phan, MD 20110 Stoneview Dr, Richmond, TX 77407-4166 Ph: (832) 798-7326 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The provision of long-term care in the U.S. has shifted from what was once a predominantly institutionally based system of care to one in which recipients can increasingly receive a range of both medical and supportive services at home and in the community, according to the latest edition of The Gerontological Society of America's Public Policy & Aging Report.
Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.
› Verified 2 days ago
Dr. Rajat S. Bhatt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7103 S Peek Rd Unit B-1, Richmond, TX 77407 Phone: 281-884-9705 Fax: 888-844-2976 | |
Maya Susan Varkey, NP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8119 Cheyenne Hills Trl, Richmond, TX 77406 Phone: 773-430-5838 | |
Nitesh Vachhani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Main St Ste 401, Richmond, TX 77469 Phone: 281-342-9530 Fax: 281-342-9564 | |
Dr. Aisha B Khattak, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8002 Fm 1464 Rd Ste 300, Richmond, TX 77407 Phone: 832-400-2733 Fax: 832-400-2734 | |
Dr. James R. Mcclamroch, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 22001 Southwest Fwy, Suite 210, Richmond, TX 77469 Phone: 281-238-7825 | |
Dr. Long Bao Cao, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Main St Ste 105, Richmond, TX 77469 Phone: 281-633-4925 Fax: 281-633-4929 |